Research Trial for Pediatric Plaque Psoriasis

Individuals aged 6 to less than 18 years old with a diagnosis of chronic plaque psoriasis for at least 6 months, may qualify to participate.

The study consists of 4 parts, each with distinct populations:

  • Part 1: for adolescents (aged 12 to less than 18 years old) with severe disease involving 20% or more body surface area (or 10% or more body surface area that includes facial or genital areas).
  • Part 2: for adolescents (aged 12 to less than 18 years old) with moderate to severe disease involving 10% or more body surface area.
  • Part 3: for children (aged 6 to less than 12 years old) with severe disease involving 20% or more body surface area (or 10% or more body surface area that includes facial or genital areas).
  • Part 4: for children (aged 6 to less than 12 years old) with moderate to severe disease involving 10% or more body surface area.

As the study progresses, some parts may no longer be enrolling.

Parts 1, 3, and 4 are open-label and all participants will receive investigational medication (active study drug), via injection. In Part 2, participants will receive one of two active study drugs during Period A; medication assignment may then change for Period B. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation in Parts 1, 3, and 4 will be about 65 weeks and involve about 9 visits to the study centre, plus a follow-up phone call.

In Part 2, study duration may be longer (81 weeks) and involve additional visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more